Rare disease drugmakers seek exclusion from Medicare pricing plans
WASHINGTON — Biotech companies are lobbying the Trump administration to exclude treatments for rare diseases from programs that…
Pharmalittle: Drug shortages rise, GSK cough medicine trials fail
And so, another working week will soon draw to a close. Not a moment too soon, yes? This…
Sales from controversial U.S. drug discount program rose to $100B last year
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He…
Pharmalittle: RFK Jr. pushes against SSRIs, wearable drug okayed
Good morning, everyone, and welcome to another working week. And of course, it is nice to see you…
Kennedy presses ahead with plans to reduce antidepressant use
Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the…
ARPA-H invests $160 million to make custom gene editing routine
ARPA-H, the U.S.’ “moonshot” agency for health research, announced Thursday that it will spend up to $160 million…
How one father built a biotech, Grace Science, to save his daughter
Highlights Matt Wilsey has spent a decade and $70 million trying to develop a cure for his daughter…
AstraZeneca, Ionis report major trial failure with heart disease drug
Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially…
Secret shopper study reveals questionable telehealth GLP-1 practices
Katie covers the impact of health technology on patients, clinicians, and businesses. Her stories explore the price tag…
Colorado’s first-of-its-kind price cap on an Amgen drug blocked
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He…
NIH All of Us Research Program taps health records to fill gaps
Katie covers the impact of health technology on patients, clinicians, and businesses. Her stories explore the price tag…
Anthropic releases Claude Science, sees Claude Code level impact
Brittany Trang, Ph.D., covers AI in health and medicine: Does it actually work? Who benefits, or might be…